1.0
Cite Score 2025
SJR: 0.129 / SNIP: 0.140
JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
Volume 18, Issue 1 (2026)
3 2026, 18(1): 1-8 |
Back to browse issues page
History
Received: 2026/11/1 | Accepted: 2026/01/20 | Published: 2026/01/29
Received: 2026/11/1 | Accepted: 2026/01/20 | Published: 2026/01/29
How to cite this article
Dawood S, Nader M. Association of miR-146a Gene Expression with Inflammation of Type 2 Diabetes Mellitus Patients. 3 2026; 18 (1) :1-8
URL: http://ijwph.daneshafarand.org/article-3-85669-en.html
URL: http://ijwph.daneshafarand.org/article-3-85669-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Al Shahed Mohammed Baqer Alhakim Hospital, Ministry of Health, Baghdad, Iraq
2- Institute of Genetic Engineering and Biotechnology, University of Baghdad, Baghdad, Iraq
2- Institute of Genetic Engineering and Biotechnology, University of Baghdad, Baghdad, Iraq
Abstract (606 Views)
Aims: The prevalence of type 2 diabetes mellitus is increasing dramatically worldwide. Dysregulation of microRNAs, key regulators of gene expression, has been reported in numerous diseases, including diabetes. The aim of this study was to investigate miRNA-146a expression levels in patients with diabetes and healthy individuals and to determine whether changes in miRNA-146a levels are reliable biomarkers for diagnosis, prognosis, and pathogenesis of type 2 diabetes mellitus.
Materials & Methods: In this case-control study, participants (n=150) were allocated to two groups; type 2 diabetes mellitus (n=100/group) and healthy individuals (n=50/group) as controls (males and females, age: 40-70, body mass index: 25-35). Expression of miRNA was determined by real-time polymerase chain reaction. Furthermore, serum concentrations of TNF-α, IL-1β, and fasting insulin were measured by enzyme-linked immunosorbent assay. Homeostatic model assessment for insulin resistance was calculated as an indicator of insulin resistance.
Findings: miR-146a was lower in diabetic patients, as evidenced by higher ΔCt values (p<0.01). Furthermore, the pro-inflammatory cytokine levels were much higher among diabetic patients than in controls. That is, IL-1β was significantly (p<0.01) higher in diabetics (93.9pg/ml; IQR: 50.1-122) than in controls (65.9pg/ml; IQR: 51.8-76.8). Similarly, TNF-α levels were significantly (p<0.0001) higher in diabetic individuals (26.1pg/ml; IQR: 17.1-31.6) than in healthy controls (16.1pg/ml; IQR: 13.5-20.9).
Conclusion: These findings indicate an increased pro-inflammatory state in patients with type 2 diabetes mellitus.
Materials & Methods: In this case-control study, participants (n=150) were allocated to two groups; type 2 diabetes mellitus (n=100/group) and healthy individuals (n=50/group) as controls (males and females, age: 40-70, body mass index: 25-35). Expression of miRNA was determined by real-time polymerase chain reaction. Furthermore, serum concentrations of TNF-α, IL-1β, and fasting insulin were measured by enzyme-linked immunosorbent assay. Homeostatic model assessment for insulin resistance was calculated as an indicator of insulin resistance.
Findings: miR-146a was lower in diabetic patients, as evidenced by higher ΔCt values (p<0.01). Furthermore, the pro-inflammatory cytokine levels were much higher among diabetic patients than in controls. That is, IL-1β was significantly (p<0.01) higher in diabetics (93.9pg/ml; IQR: 50.1-122) than in controls (65.9pg/ml; IQR: 51.8-76.8). Similarly, TNF-α levels were significantly (p<0.0001) higher in diabetic individuals (26.1pg/ml; IQR: 17.1-31.6) than in healthy controls (16.1pg/ml; IQR: 13.5-20.9).
Conclusion: These findings indicate an increased pro-inflammatory state in patients with type 2 diabetes mellitus.
Keywords:
References
1. Ridha R, Kandala N. Association of genetic polymorphisms in a sample of Iraqi patients with type 2 diabetes mellitus. Iraqi J Biotechnol. 2016;15(3). [Link]
2. Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes mellitus: Insights from epidemiology, biochemistry, risk factors, diagnosis, complications, and comprehensive management. Diabetology. 2021;2(2):36-50. [Link] [DOI:10.3390/diabetology2020004]
3. Patterson C, Harjutsalo V, Rosenbauer J, Neu A, Cinek O, Skrivarhaug T, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centers in the 25 year period 1989-2013: A multicenter prospective registration study. Diabetologia. 2019;62(3):408-17. [Link] [DOI:10.1007/s00125-018-4763-3]
4. Cho NH, Shaw JE, Karuranga S, Huang Y, Da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-81. [Link] [DOI:10.1016/j.diabres.2018.02.023]
5. Lateef A, Mohammed B. Effect of age on apoptosis and necrosis of peripheral blood lymphocytes in sample of Iraqi type 2 diabetes patients. Iraqi J Biotechnol. 2023;22(1). [Link]
6. Al-Ayash M, Nader M. Long non-coding RNA-H19 and miRNA-29a expression in type 2 diabetes mellitus patients. Romanian J Diabetes Nutr Metab Dis. 2025;32(3):253-61. [Link]
7. Jwad M, Gharbi W. Determination of IFN-y in patients with pseudomonas aeruginosa-inflicted burn and wound. REVISTA BIONATURA. 2022;7(4):2. [Link] [DOI:10.21931/RB/2022.07.04.2]
8. Mudhaffer N, Hassan IA. Expression and polymorphisms of the IRS1 gene as related with the risk of type 2 diabetes mellitus in Iraqi patients. Int J Endocrinol. 2025;21(7):708-12. [Link] [DOI:10.22141/2224-0721.21.7.2025.1636]
9. Shojima N, Yamauchi T. Progress in genetics of type 2 diabetes and diabetic complications. J Diabetes Investig. 2023;14(4):503-15. [Link] [DOI:10.1111/jdi.13970]
10. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: Standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S19-40. [Link] [DOI:10.2337/dc23-S002]
11. Abdel-Moneim A, Abd El-Twab SM, Nabil A, El Kazafy SA. Effect of antidiabetic therapy on TNF-α, IL-18, IL-23 and IL-35 levels in T2DM patients with coincidental Helicobacter pylori infection. J Taibah Univ Sci. 2020;14(1):1377-85. [Link] [DOI:10.1080/16583655.2020.1824669]
12. Tian J, Zhao Y, Wang L, Li L. Role of TLR4/ MyD88/ NF-κB signaling in heart and liver-related complications in a rat model of type 2 diabetes mellitus. J Int Med Res. 2021;49(3):300060521997590. [Link] [DOI:10.1177/0300060521997590]
13. Sahan K, Aziz I, Dawood S, Razzaq S. Evaluation of miR-146 and miR-196 as potential biomarkers in a sample of Iraqi breast cancer patients. REVISTA BIONATURA. 2023;8(2):1-10. [Link] [DOI:10.21931/RB/CSS/2023.08.02.8]
14. Benko J, Sarlinova M, Mikusova V, Bolek T, Pec MJ, Halasova E, et al. MiR-126 and miR-146a as markers of type 2 diabetes mellitus: A pilot study. Bratisl Lek Listy. 2023;124(7):527-33. [Link] [DOI:10.4149/BLL_2023_081]
15. Haneen AA, Essam FJ. The relationship between some biochemical parameters and type 2 diabetes mellitus among Iraqi patients. Iraqi J Biotechnol. 2022;21(2). [Link]
16. Elimam H, Abdulla A, Taha I. Inflammatory markers and control of type 2 diabetes mellitus. Diabetes Metab Syndr. 2019;13(1):800-4. [Link] [DOI:10.1016/j.dsx.2018.11.061]
17. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98-107. [Link] [DOI:10.1038/nri2925]
18. Ying W, Fu W, Lee YS, Olefsky JM. The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities. Nat Rev Endocrinol. 2020;16(2):81-90. [Link] [DOI:10.1038/s41574-019-0286-3]
19. Peiró C, Lorenzo Ó, Carraro R, Sánchez-Ferrer CF. IL-1β inhibition in cardiovascular complications associated to diabetes mellitus. Front Pharmacol. 2017;8:363. [Link] [DOI:10.3389/fphar.2017.00363]
20. Acharya AB. Evaluation of systemic cytokines IL-1β, IL-4, IL-6, IL-10 and TNF-α in health, chronic periodontitis and type 2 diabetes mellitus [dissertation]. Bengaluru: Rajiv Gandhi University of Health Sciences; 2016. [Link] [DOI:10.15406/jdhodt.2017.06.00188]
21. Younus A, Al-Faisal A. Correlation of toll-like receptor 4 and tumour necrosis factor Alfa with type-2 diabetes mellitus. J Eng Sci Technol. 2024;19(3):880-93. [Link] [DOI:10.1016/j.jtumed.2024.04.005]
22. Berbudi A, Khairani S, Tjahjadi AI. Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: Implications for therapeutic interventions. Immunotargets Ther. 2025;14:359-82. [Link] [DOI:10.2147/ITT.S499605]
23. Akash M, Rehman K, Liaqat A. Tumor necrosis factor‐alpha: Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119(1):105-10. [Link] [DOI:10.1002/jcb.26174]
24. Pucelik B, Barzowska A, Dąbrowski JM, Czarna A. Diabetic Kinome inhibitors-a new opportunity for β-Cells restoration. Int J Mol Sci. 2021;22(16):9083. [Link] [DOI:10.3390/ijms22169083]
25. Al-Kinani HJA. Genotype analysis of hepatocyte nuclear factor 1A gene and miRNA-122 5p expression in patients with maturity-onset diabetes of the young type 3 (MODY3) in Baghdad province [dissertation]. Baghdad: University of Baghdad; 2023. [Link]
26. Al-Saffar E, AL-Saadi B, Awadh N. Study the association of miRNA-146a gene polymorphism and some immunological markers with the risk of Rheumatoid Arthritis incidence in a sample of Iraqi patients. REVISTA BIONATURA. 2023;8(2):1-14. [Link] [DOI:10.21931/RB/CSS/2023.08.02.22]
27. Liu S, Da Cunha AP, Rezende RM, Cialic R, Wei Z, Bry L, et al. The host shapes the gut microbiota via fecal MicroRNA. Cell Host Microbe. 2016;19(1):32-43. [Link] [DOI:10.1016/j.chom.2015.12.005]
28. Ghaffari M, Razi S, Zalpoor H, Nabi-Afjadi M, Mohebichamkhorami F, Zali H. Association of MicroRNA-146a with type 1 and 2 diabetes and their related complications. J Diabetes Res. 2023;2023:2587104. [Link] [DOI:10.1155/2023/2587104]
29. Sanada T, Sano T, Sotomaru Y, Alshargabi R, Yamawaki Y, Yamashita A, et al. Anti-inflammatory effects of miRNA-146a induced in adipose and periodontal tissues. Biochem Biophys Rep. 2020;22:100757. [Link] [DOI:10.1016/j.bbrep.2020.100757]
30. Sabio G, Davis RJ. cJun NH2-terminal kinase 1 (JNK1): Roles in metabolic regulation of insulin resistance. Trends Biochem Sci. 2010;35(9):490-6. [Link] [DOI:10.1016/j.tibs.2010.04.004]
31. Naidu C, Cox A, Lewohl J. Influence of sex and liver cirrhosis on the expression of miR-146a-5p and its target genes, IRAK1 and TRAF6. Brain Res. 2024;1827:148763. [Link] [DOI:10.1016/j.brainres.2024.148763]
32. Zhou H, Ni W, Meng X, Tang L. MicroRNAs as regulators of immune and inflammatory responses: Potential therapeutic targets in diabetic nephropathy. Front Cell Dev Biol. 2021;8:618536. [Link] [DOI:10.3389/fcell.2020.618536]